Related Experiment Video
Updated: Oct 13, 2026

A Protocol for Comprehensive Assessment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis (ALS)
Published on: February 21, 2011
Spasmodic dysphonia symptoms as initial presentation of amyotrophic lateral sclerosis
C R Roth1, L E Glaze, G S Goding
1Department of Speech-Language Pathology, Hennepin Country Medical Center, Minneapolis, MN 55415, USA.
Abstract:
A patient initially diagnosed with adductor-type spasmodic dysphonia was referred for botulinum toxin (Botox) injections, but found on subsequent evaluation to have amyotrophic lateral sclerosis, and therefore Botox was not administered. This unique case underscores the need to delay botulinum toxin treatments in any patient with recent onset symptoms, and to obtain thorough motor speech and voice, otolaryngologic, and neurologic evaluation in all patients prior to consideration for injection.
Related Concept Videos
Cross-bridge Cycle
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Multiple Sclerosis l: Introduction
Myasthenia Gravis ll: Pathophysiology
Alterations in Muscle Tone ll
Alterations in Muscle Tone lll

